Home
Clinical Trials
National Survey on Hypertensi...

National Survey on Hypertension in General Practitioner (GP) Consultation

Last Updated: 2009-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2853 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male or female \> or = 18 years old
* Known hypertension
* agree to take part in this study

Exclusion Criteria

* none

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca Pharmaceuticals

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Castaigne, Medical Director

Role: STUDY_DIRECTOR

AstraZeneca

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CFR-DUM-2007/7

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Target Organs Damage in Hypertensive Patients

NCT01055353 COMPLETED

Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)

NCT02268071 COMPLETED NA

Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals

NCT01753206 COMPLETED

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension

NCT03078244 COMPLETED

National Tunisian Registry of Hypertension

NCT04013503 COMPLETED

The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

NCT01295021 COMPLETED

Retrospective Survey for Patients With Hypertension and Diabetes Mellitus

NCT00681278 COMPLETED

Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension

NCT00771069 COMPLETED

Hypertensive Treatment and Epidemiological Analyses

NCT00005501 COMPLETED

Ambulatory Blood Pressure and Prognosis

NCT00005363 COMPLETED

Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients

NCT05991089 COMPLETED

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

NCT05535595 COMPLETED PHASE4

Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease

NCT05814068 UNKNOWN NA

Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke

NCT00681707 COMPLETED

From Micro- to Macro-vessels : Water, Salt, Heart and Kidneys

NCT05114291 COMPLETED

Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

NCT02202525 COMPLETED

Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health

NCT02972619 UNKNOWN NA

Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population

NCT00901355 COMPLETED

Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients

NCT02133872 COMPLETED PHASE2

Monitoring of the Influence of Approved PH-therapies RV-PA Coupling

NCT05935865 RECRUITING

Registry of Arterial Hypertension

NCT04160533 UNKNOWN

Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects

NCT03001271 UNKNOWN EARLY_PHASE1

High Blood Pressure in the Young

NCT00005138 COMPLETED

Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension

NCT05638503 RECRUITING

Effect of Different Antihypertensive Treatment on Serum Uric Acid in Newly Diagnosed Hypertensive Patients

NCT04554069 UNKNOWN

National Survey on Hypertension in General Practitioner (GP) Consultation

Study Results

Basic Information

Brief Summary

Related Clinical Trials

National Survey on Hypertension at Hospital

National Survey on Hypertension in Cardiologic Private Practice